Jarod Horobin/LinkedIn
Oct 21, 2026, 09:13
Jarod Horobin: Blood 2026 – Connecting Science and People
Jarod Horobin, General Manager of Clinical Research at Perth Blood Institute, shared a post on LinkedIn:
“Blood 2026 – what a great event!
Thank you to Thrombosis and Haemostasis Society of Australia and New Zealand, Haematology Society of Australia and New Zealand, ANZSBT, sponsors, speakers, organisers, and everyone who attended.
It was wonderful to reconnect with colleagues, build new relationships, and hear about the impressive research taking place across the blood and bleeding disorders community.
Looking forward to bringing some new ideas and connections back to Perth Blood Institute.
Already looking forward to next year.”
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 08:35Raeeda Gheewala: VTE in Athletes – Risks Beyond the Playing Field
-
Oct 21, 2026, 08:29Andreas Kronbichler: The Changing Landscape of CV Risk in ANCA-Associated Vasculitis
-
Oct 21, 2026, 08:21Pham Quy: Taking Stroke Awareness Beyond Hospitals and Into the Community
-
Oct 21, 2026, 07:15Mahmoud Saad: Successful Mechanical Thrombectomy for Right Atrial Thrombosis
-
Oct 21, 2026, 06:55Hunain Shahbaz: Extended Dual Antiplatelet Therapy Beyond 12 Months After Drug-Eluting Stent Implantation
-
Oct 21, 2026, 06:19Dawood Findakly: When Should Anticoagulation Be Held or Resumed?
-
Oct 21, 2026, 03:36Steve Watson: Ligand Epitope Ratios Influence Antagonist Inhibition
-
Oct 21, 2026, 03:18Stephen D. Coombs: Superficial Venous Thrombosis in Athletes and Importance of Early Recognition and Referral
-
Oct 21, 2026, 02:52Aymar Akilimali: Bleeding During Anticoagulation as a Potential Signal of Occult Cancer